Kevin Robinson | Editor

Articles and archive:

Active Nutrition | Analysis | Cell & Gene Therapy | Containment | Contamination Control | Digital | Distribution | Dosage Forms | Drug Delivery | Finance | Food | Hi Tech Manufacturing | Ingredients | Logistics | Manufacturing | Marketing | Media | Medical Devices | Packaging | Pharma 5.0 | Pharmaceutical | Regulatory | Research & Development | Sustainability

Dr Kevin Robinson is a former molecular biologist turned writer, publishing executive and editor with extensive media experience in the life science, pharmaceutical and nutraceutical sectors

Kevin Robinson

Related content

Packaging
Schreiner MediPharm develops multifunctional label for SHL Medical’s Quanta Pen

Schreiner MediPharm develops multifunctional label for SHL Medical’s Quanta Pen

The global market for weight management drugs is seeing dynamic growth and increases the demand for powerful self-injection systems
Research & Development
Akiram and ITM sign supply agreement to develop AKIR001 to treat solid tumours

Akiram and ITM sign supply agreement to develop AKIR001 to treat solid tumours

AKIR001 is a targeted antibody-radionuclide conjugate designed to deliver radiation directly to CD44v6-expressing solid tumours, with potential to become a first-in-class therapy
Research & Development
Lupin advances speciality pipeline with FDA approval and European partnership

Lupin advances speciality pipeline with FDA approval and European partnership

Lupin has recently announced two significant developments, reinforcing its momentum in both the US generics market and its global speciality care strategy
Analysis
MaxCyte launches CHANGE-seq-BE and ONE-seq-BE to strengthen off-target assessment for genome editing therapies

MaxCyte launches CHANGE-seq-BE and ONE-seq-BE to strengthen off-target assessment for genome editing therapies

The launch comes as base editing advances toward the clinic and regulators place greater emphasis on sensitive, orthogonal approaches to genome safety
Sustainability
Bespak awarded gold EcoVadis sustainability rating for its Holmes Chapel (UK) site

Bespak awarded gold EcoVadis sustainability rating for its Holmes Chapel (UK) site

Bespak, the specialist inhalation CDMO, has achieved a Gold EcoVadis sustainability rating for its Holmes Chapel site. The result places Bespak among the top 5% of companies assessed worldwide
Analysis
Custom PCR solutions for diagnostic kit manufacturers

Custom PCR solutions for diagnostic kit manufacturers

Drawing on its trusted 4titude portfolio of PCR products, Azenta Life Sciences has built a reputation for partnering with diagnostic kit manufacturers to develop consumables tailored to their specific workflows
Research & Development
First commercial kidney transplant patient treated with Idefirix in Australia

First commercial kidney transplant patient treated with Idefirix in Australia

Imlifidase is an antibody-cleaving enzyme originating from Streptococcus pyogenes that specifically targets and cleaves immunoglobulin G (IgG) antibodies and inhibits IgG-mediated immune response
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development
The future of science is built on networks, not laboratories

The future of science is built on networks, not laboratories

More often than not, life science innovation depends on decades of international collaboration, shared infrastructure and open exchange of data, Plamena Markova, Head of International Relations at the European Molecular Biology Laboratory (EMBL), tells Dr Kevin Robinson
You need to be a subscriber to read this article.
Click here to find out more.
Distribution
Closing the gap between strategy and resilience in pharmaceutical supply chains

Closing the gap between strategy and resilience in pharmaceutical supply chains

Pharmaceutical manufacturers must align technology, operations and visibility to build resilient supply chains amid shortages, rising costs and geopolitical instability
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development
Precision medicine and the fight to revive neuroscience R&D

Precision medicine and the fight to revive neuroscience R&D

In discussion with Dr Kevin Robinson (KSR), Neurvati’s Dr Bruce Leuchter (BL) explores how biology-led development, better diagnosis and rare disease infrastructure could help to unlock stalled neuroscience programmes
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
Back to basics: a simple guide to checkweighing in pharmaceutical production

Back to basics: a simple guide to checkweighing in pharmaceutical production

Mettler-Toledo’s Miriam Krechlok tells Dr Kevin Robinson how checkweighing helps pharmaceutical manufacturers to verify product completeness, control fill levels and maintain compliance, safety and efficiency
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development
Where nanoengineering meets drug formulation

Where nanoengineering meets drug formulation

How Nanexa is turning short-acting drugs into long-acting injectables